Pharmagene Laboratories Limited

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 75.0

Trademarks = 1

Forward Citations = 14

Loading Chart...

18 inventors (with patents filed for the assignee):

Richard Jon Davis (2 out of 11 patents)

George Hynd (1 out of 39 patents)

Jonathan Mark Sutton (1 out of 33 patents)

4. David Edward Clark (1 out of 26 patents)

5. Shirley Ann Brunton (1 out of 8 patents)

6. Edward Andrew Boyd (1 out of 33 patents)

7. Nicholas Tilford (1 out of 2 patents)

8. Mark Richard Ashton (1 out of 9 patents)

9. Robert Alexander Coleman (1 out of 12 patents)

10. Kenneth Lyle Clark (1 out of 16 patents)

11. Neil Victor Harris (1 out of 11 patents)

12. Garry Fenton (1 out of 12 patents)

13. Keith Alfred James Stuttle (1 out of 6 patents)

14. Gordon Smith Baxter (1 out of 2 patents)

15. Keith J Page (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 7326732 - EP2 receptor agonists (2008-02-05),

2. 6780839 - Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) (2004-08-24),

3. 6551783 - Quantitative analysis of gene expression using PCR (2003-04-22),

4. 6444477 - Assay method for detecting 5-HT2B antagonists (2002-09-03),

Company Overview

Pharmagene Laboratories Limited is a leading pharmaceutical company specializing in research and development of innovative medicines. With a focus on personalized medicine and cutting-edge technologies, Pharmagene is committed to improving global health by delivering safe and effective treatments for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

4 Patents

#14 in Royston

#3,876 in United Kingdom

Royston, United Kingdom